Business Angels des Grandes Ecoles

PEP-Therapy SAS is a biotechnology company based in Evry, France, founded in 2014. The company specializes in the development of cell penetrating and interfering peptides (CP and IP) aimed at delivering targeted therapies for severe diseases, particularly cancer. One of its key products is DPT-PEP1, a peptide designed to inhibit Caspase-9/PP2A protein interactions, effectively triggering apoptosis in cancer cells while preserving the functionality of healthy cells and other signaling pathways. By focusing on the intracellular delivery of these peptides, PEP-Therapy aims to address critical pathological mechanisms, offering a promising approach to cancer treatment.

PEP-Therapy SAS is a biotechnology company based in Evry, France, founded in 2014. The company specializes in the development of cell penetrating and interfering peptides (CP and IP) aimed at delivering targeted therapies for severe diseases, particularly cancer. One of its key products is DPT-PEP1, a peptide designed to inhibit Caspase-9/PP2A protein interactions, effectively triggering apoptosis in cancer cells while preserving the functionality of healthy cells and other signaling pathways. By focusing on the intracellular delivery of these peptides, PEP-Therapy aims to address critical pathological mechanisms, offering a promising approach to cancer treatment.

Imageens is a Paris-based company that specializes in artificial intelligence-based platforms for the analysis of medical images, particularly in the field of cardiovascular care. Founded in 2017, the company focuses on enhancing the early detection and diagnosis of cardiovascular diseases through advanced MRI image analysis. Its key products include ArtFun+, which offers morphological and functional assessments of arteries, and CardFun, designed for evaluating left ventricle diastolic function. Additionally, the Geometry tool provides comprehensive analyses of arterial geometry, while the Report Platform generates detailed reports on arterial stiffness and cardiac function. By measuring critical biomarkers associated with cardiovascular health, Imageens supports healthcare professionals, including radiologists and cardiologists, in making informed, personalized decisions to mitigate cardiovascular risks.

OncoDiag is a French biotechnology company located in Normandy, dedicated to creating non-invasive diagnostic tests aimed at the early detection of cancers. Its flagship product, the Urotest, is a urine test approved for the diagnosis and monitoring of bladder cancer. In addition to the Urotest, OncoDiag is developing Colodiag, a test focused on the early identification of colorectal cancer, and other diagnostic tools, including a tissue-based test for predicting non-evolutive localized prostate cancer. Through its innovative testing kits, OncoDiag aims to enhance cancer diagnostics, allowing healthcare professionals to provide timely and effective patient care.

WeFight Inc. develops technology for health care sector. The company develops an application called Vik-Sein, which answers patients’ questions about breast cancer. Vik provides reminders to patients when to take treatment and smart tracking book to offer clinical trials that match their profile. The company was founded in 2017 and is based in Montpellier, France.

trainme, SAS owns and operates a community platform of sports courses connecting individuals with sports professionals. The company was incorporated in 2015 and is based in Paris, France.

Cardiawave, established in late 2014 through a collaboration between the Langevin Institute and the Georges Pompidou European Hospital, focuses on developing a non-invasive ultrasonic medical device aimed at treating heart valve diseases, particularly calcified aortic stenosis. The device utilizes real-time image guidance and ultrasound technology to perform treatments without causing thermal injury, allowing clinicians to address conditions swiftly and improve the chances of successful outcomes. With a management team experienced in innovation, Cardiawave has raised over €14 million since its inception to advance its product development and conduct preclinical studies, with plans for first-in-man trials initially anticipated in 2019. The company is recognized for its contributions to the field of cardiac care, having won accolades such as the 2017 Prize at the Worldwide Innovation Contest.

Cypheme is an artificial intelligence capable of detecting counterfeit products by analyzing the product's packaging with a neural network, using only a cellphone camera.

Cardiawave, established in late 2014 through a collaboration between the Langevin Institute and the Georges Pompidou European Hospital, focuses on developing a non-invasive ultrasonic medical device aimed at treating heart valve diseases, particularly calcified aortic stenosis. The device utilizes real-time image guidance and ultrasound technology to perform treatments without causing thermal injury, allowing clinicians to address conditions swiftly and improve the chances of successful outcomes. With a management team experienced in innovation, Cardiawave has raised over €14 million since its inception to advance its product development and conduct preclinical studies, with plans for first-in-man trials initially anticipated in 2019. The company is recognized for its contributions to the field of cardiac care, having won accolades such as the 2017 Prize at the Worldwide Innovation Contest.

Telegrafik SAS is a company that specializes in developing an intelligent software platform designed to enhance safety and independence for the elderly and disabled. Founded in 2013 and based in Toulouse, France, with additional offices in Paris, Telegrafik offers a variety of services under its Otono-me brand. These include remote assistance solutions tailored for elderly individuals living alone, those with Alzheimer's disease, and residents in nursing homes. The platform utilizes data from sensors installed in homes to provide activity monitoring, behavior analysis, anomaly detection, and alert services. By transforming sensor data into actionable insights, Telegrafik aims to support both individuals and caregivers in ensuring safety and autonomy for vulnerable populations. The company's solutions are distributed through professionals in the senior care and home care sectors.

With CinéGV terminals, download in 30 seconds on a USB / micro USB or SD card, movies or series you dream to see. For all your travels, by train, by car, at the hotel ... and even at home! Wherever you are, enjoy a real movie on your computer, tablet or smartphone. Find the box office and TV hits in a prestigious catalog, regularly updated.